Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients

@article{Keene2014EffectOC,
  title={Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients},
  author={D. Keene and C. Price and Matthew J Shun-Shin and D. Francis},
  journal={The BMJ},
  year={2014},
  volume={349}
}
  • D. Keene, C. Price, +1 author D. Francis
  • Published 2014
  • Medicine
  • The BMJ
  • Objective To investigate the effects on cardiovascular outcomes of drug interventions that increase high density lipoprotein levels. Design Meta-analysis. Studies reviewed Therapeutic benefit of niacin, fibrates, and cholesteryl ester transfer protein (CETP) inhibitors on cardiovascular events (all cause mortality, coronary heart disease mortality, non-fatal myocardial infarction, and stroke). Results 117 411 patients were randomised in a total of 39 trials. All interventions increased the… CONTINUE READING
    297 Citations
    Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis
    • 9
    Role of Niacin in Current Clinical Practice: A Systematic Review.
    • 31
    An update on trials of novel lipid-lowering drugs
    • 3
    High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need
    • 4
    • PDF

    References

    SHOWING 1-10 OF 59 REFERENCES
    Effects of dalcetrapib in patients with a recent acute coronary syndrome.
    • 1,501
    • PDF
    Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
    • 2,179
    • PDF